Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
Oncology|July 23, 2009
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology GroupDimosthenis V Skarlos, Eleni Timotheadou, Eleni Galani, et al.
American Journal of Clinical Oncology|December 13, 2002
Lymphocyte subpopulations and interleukin levels in high-risk melanoma patients treated with high-dose interferon A-2BHelen Gogas, George Paterakis, Konstantina Frangia, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II studyThomas Makatsoris, Pavlos Papakostas, Haralabos P Kalofonos, et al.
European Urology|July 13, 2004
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II studyDimitrios Pectasides, Melina Pectasides, Dimitrios Farmakis, et al.
Anti-Cancer Drugs|December 17, 2009
Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I studyGeorge P Stathopoulos, Alexandros Ardavanis, Pavlos Papakotoulas, et al.
Biology|March 19, 2020
Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) StudyAnna Koumarianou, Dimitrios Pectasides, Georgia-Angeliki Koliou, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2016
Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experienceNikolaos Papadopoulos, Melanie Deutsch, Spilios Manolakopoulos, et al.
Cancer Medicine|December 10, 2015
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trialsAgnieszka Malczewski, Andrea Marshall, Miranda J Payne, et al.
Gynecologic Oncology|May 3, 2005
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experienceDimitrios Pectasides, George Fountzilas, Gerasimos Aravantinos, et al.
Cancer|June 16, 2010
Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferonHelen Gogas, John M Kirkwood, Christine S Falk, et al.
Pageof 19